Navigation Links
Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib

Indian Pharmaceuticals companies Glenmark pharma and Nicholas Piramal has withdrawn their drug Valdecoxib from the Indian market after USFDA ban the sale of Valdecoxib formulation products and the recent notification issued by // the health ministry of the government of India asking the pharma companies to stop selling and production of Valdecoxib. Ranbaxy as already withdrew the drug from the market after the suggestions of the National Pharmacological vigilance Advisory Committee.

Glenmark Pharma had a major market share in this drug Valdecoxib was at Rs. 25 crores, which subsequently dropped to around Rs. 12 crores, whereas Nicholas had about Rupees 12 crores. Mr. A.S. Mohanty of Glenmark said, “The Indian market abides by the norms laid down by the Drugs Controller General of India. The drug control had advised us to discontinue the manufacture and sale of Valdecoxib in India recently. We had stopped producing and marketing formulations containing Valdecoxib in India. We have recalled all the existing stocks from the market”. Glenmark has plans of replacing Valdecoxib with other alternate molecules for treatment of pain relief. He said, “Our pain management portfolio has several other brands based on molecules such as Etoricoxib and Aceclofenac, which are being promoted to replace Valdecoxib.
'"/>




Page: 1

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ing in a French school, hospital, metro station, o...e first time to a stiff fine as the first stage of... places went into effect. The ban covers schools,...' offices, sports halls, train stations, airports,...
...ng an outbreak of bird flu in a poultry farm in Su... Reports of an ‘unexplained’ illness// had many ex...ion has been received from The Department of Envir... bird-flu outbreak. This is the second attack of b...
...lipid plays a crucial role in shaping a hollow sph...ave found. It seems to help in organizing// tissue...tions. They found that in the first few days of l...p to form the primitive ectoderm from which embryo...
...lege of Medicine finds that naltrexone may be bene...of this drug is often used to bring// relief to vi...ase is a chronic inflammatory disorder of the inte...0 Americans. The study results were released onlin...
Other Medicine News:Health News:Ceramide Directs Stem Cells in Embryo 2
(Date:9/4/2008)...LBOURNE, Australia, Sept. 4 /- Cytopi...mmencing enrolment for its Phase Ib/II,study of CY...cancer agent,in patients with an aggressive form ...GBM)., The GBM clinical trial is the first Phase ...indications for the company and the second in its,...
(Date:9/4/2008)...actice Bulletin for Obstetrician-Gynecologists Sta...ce Change-Minimally Invasive Interventional,Radiol...With Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /PRN...al Radiology, a national organization of nearly 4,...onals dedicated to improving health,care through m...
(Date:9/4/2008)...mg cohort demonstrates potent antiviral activity a...profile -, CAMBRIDGE, Mass., Sept. 4 /PRNewswire-...: IDIX ), a biopharmaceutical company engaged,in ...atment of human viral,and other infectious disease...-of-concept study evaluating IDX899, a non-nucleos...
(Date:9/3/2008)...NJING, China, Sept. 3 /- Si...g manufacturer and supplier of,branded generic pha...-cancer biotech product Endu (also known as Endost...u Phase IV clinical study., At the request of the...,to further validate the safety and therapeutic ef...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3First study examines newly licensed RN work attitudes and intentions 234 1First study examines newly licensed RN work attitudes and intentions 234 2First study examines newly licensed RN work attitudes and intentions 234 3RA Drugs Linked to Slight Skin Cancer Risk 232 1RA Drugs Linked to Slight Skin Cancer Risk 232 2Who will recover spontaneously from hepatitis C virus infection 175 1Who will recover spontaneously from hepatitis C virus infection 175 2Modigene to Present at the Roth 2007 New York Investor Conference 240 1Modigene to Present at the Roth 2007 New York Investor Conference 240 2Modigene to Present at the Roth 2007 New York Investor Conference 240 3
...ELD, Ill., March 29, 2007 /PRNewswire-FirstCall/ -...Phase I/II data for its,adjuvant-free investigatio...nitiate a Phase III clinical trial of the candidat..., The Phase I/II study indicated that Baxter,s H5N...oses, and induces substantial,levels of cross immu...
...ascular Ultrasound Demonstrates Utility in Evaluat...normous Potential for HDL,Therapy , ,PLEASANTON, C...rk),-- Lipid Sciences, Inc. (NASDAQ: LIPD) Dr. H. ...pid Sciences, Inc., concluded from,the wide range ...,Cardiology (ACC) Meeting in New Orleans that the ...
Other Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5
This storage freezer, which is based on our premium freezer line, maintain red cells safely below regulatory standards at -86C (-123F). Recorder is standard for model 8627. Model 8627 is UL Listed, C
...irements of blood banking and processing applicati...can Association of Blood Banks (AABB), American Na...istration (FDA) standards. Refrigerators, storage ...stems that alert you of critical power failures or...
...irements of blood banking and processing applicati...can Association of Blood Banks (AABB), American Na...istration (FDA) standards. Refrigerators, storage ...stems that alert you of critical power failures or...
This refrigerator is specially designed for the storage of blood in standard 500ml bags, complying with Australian Standard AS3864 1997. Quiet hermetic refrigeration is air-cooled utilising CFC Free
Medicine Products: